8/28/2014 12:34:51 PM
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and other members of Enanta management will participate in the following three investor conferences during the month of September:
Help employers find you! Check out all the jobs and post your resume.
comments powered by